Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX · NASDAQ Global Select
-$6.43 today
Vol 2.67M · Avg 1.26M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+1.82%
Period High
$499.17
Period Low
$366.54
Latest
$451.63
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$125.68B
Stryker Corporation
NYSE:SYK
$118.98B
Bristol-Myers Squibb Company
NYSE:BMY
$110.01B
GSK plc
NYSE:GSK
$101.86B
Sanofi
NASDAQ:SNY
$101.42B
Medtronic plc
NYSE:MDT
$101.25B
McKesson Corporation
NYSE:MCK
$87.89B
HCA Healthcare, Inc.
NYSE:HCA
$83.43B
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$61.95B
argenx SE
NASDAQ:ARGX
$54.50B
What is the latest VRTX filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does VRTX have?
Intrinsic Alpha currently shows 20 recent filings for VRTX.
Explore More
Continue the stock analysis
Jump to another research area for this company.